Flagship Pioneering has been granted a patent for conjugates consisting of a recognition element linked to a pharmaceutical or diagnostic agent. The invention allows for targeted drug delivery and diagnostic applications. GlobalData’s report on Flagship Pioneering gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Flagship Pioneering, Cancer treatment biomarkers was a key innovation area identified from patents. Flagship Pioneering's grant share as of May 2024 was 5%. Grant share is based on the ratio of number of grants to total number of patents.
A recently granted patent (Publication Number: US11998610B2) discloses a novel conjugate or pharmaceutically acceptable salt thereof, which is characterized by a specific chemical structure. This conjugate is claimed to have potential therapeutic applications and can be used in the development of pharmaceutical compositions. The patent also covers a pharmaceutical composition that includes the aforementioned conjugate or its pharmaceutically acceptable salt, along with a pharmaceutically acceptable excipient.
The patent's claims highlight the unique structure of the conjugate and its potential use in pharmaceutical formulations. By combining the conjugate with a pharmaceutically acceptable excipient, the pharmaceutical composition aims to provide a stable and effective dosage form for potential therapeutic use. This innovation opens up new possibilities for drug development and delivery, offering a promising avenue for further research and development in the field of pharmaceuticals.
To know more about GlobalData’s detailed insights on Flagship Pioneering, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
